Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building - SME
₹ 33.3
₹ 111
1200
₹ 1,33,200.00
NSE - SME
29-Mar-2023
03-Apr-2023
13-Apr-2023
Initial public issue of 3000000 equity shares of face value of Rs. 10/- each of Sotac Pharmaceuticals Limited (SPL or the Company or the Issuer) for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share (the Issue Price) aggregating to Rs. 33.30 crores (The Issue), of which 150000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share aggregating to Rs. 1.67 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of 2850000 equity shares of face value of Rs. 10/- each at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share aggregating to Rs. 31.63 crores is herein after referred to as the Net Issue. The issue and the net issue will constitute 27.15% and 25.79%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each.
To meet working capital requirements. Investment in subsidiary. Upgradation/construction of existing /new building in the existing premises. General corporate purposes.
Sotac Pharmaceuticals Ltd, Karvy Selenium Tow-B, 31&32 Financial Dist, Nanakramguda, Hyderabad-500032
Phone - 91-40-67162222
Fax - 91-40-23001153/23420814
Email - compliance@sotacpharma.com
Website - www.sotacpharma.com